Hit enter to search or ESC to close
Menu
Home
Biocellvia
Therapeutic Areas
Preclinical
Clinical
Tailor-made assay
Publications
Contact
Filter
All
COPD
IPF
NASH / NAFLD
PAH
Paris Nash 2021
Poster
2016-A : AUTOMATED AI-BASED MORPHOMETRIC ANALYSIS OF FIBROSIS REVEALS SIGNIFICANT CHANGES IN T2DM VS NON-T2DM MASH PATIENTS WITH ADVANCED FIBROSIS
Morphometric Digital Pathology Analysis Reveals Differential Effects Of Lanifibranor And Semaglutide In The Biopsy-Confirmed Gan Dio-Nash Mouse Model
MORPHOMETRIC DIGITAL PATHOLOGY CONFIRMS CLINICAL TRANSLATABILITY FOR LANIFIBRANOR AND SEMAGLUTIDE IN BIOPSY-CONFIRMED GAN-DIO-NASH MICE
MORPHOQUANT-LIVER, AN AUTOMATED PATHOLOGIST-INDEPENDENT MORPHOMETRIC SOFTWARE, IDENTIFIED SIGNIFICANT DIFFERENCES BETWEEN STEATOTIC AND MASH LIVER BIOPSIES
Morphometric Analysis Of Sonic Hedgehog In Non-Alcoholic Fatty Liver And Steatohepatitis Patients By Morphoquant: A Potential Biomarker Of Disease Severity
Morphoquanttm The First Fully-Automated Morphometric Software For The Assessment Of Liver Biopsy, Reveals Significant Differences Between Non- Alcoholic Fatty Liver And Steatohepatitis Biopsies
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
High-Throughput, Automated Analysis Of Blood Vessel Histomorphometry In Two Rat Models Of Pulmonary Arterial Hypertension
Dual High-Throughput Automated Analysis Of Histomorphometric Markers Of Fibrosis And Emphysema In Two Bleomycin-Induced Mouse Models Of Pulmonary Fibrosis
Selective Adipocyte Loss Of Angiopoietin-2 Prompts Female-Specific Obesity And Metabolic Syndrome
Automated Whole Slide Image Analysis For A Translational Quantification Of Liver Fibrosis
Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion
The Telomerase Activator TA‐65 Protects From Cigarette Smoke‐Induced Small Airway Remodeling In Mice Through Extra‐Telomeric Effects
Cigarette Smoke-Induced Gasdermin D Activation In Bronchoalveolar Macrophages And Bronchial Epithelial Cells Dependently On NLRP3
Distribution Of Lipid Vesicle Size As Potential Marker Of Nas Severity: Assessment With Morphoquant-Nash And Mri
Time-efficient and Reliable Automated Liver Fibrosis Quantification in Preclinical Fibrosis Models using WSI
Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
CSF1R Inhibition Prevents Radiation Pulmonary Fibrosis By Depletion Of Interstitial Macrophages
Radiation-induced lung fibrosis is associated with M2 interstitial and hybrid alveolar macrophages
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects
Follow-up of NAFLD/NASH progression using an automated histological image analysis
Fully Automated Histology Analysis Correlates with Ashcroft Scoring, MicroCT Analysis and Lung Function Measurement in a Mouse Model of Bleomycin-induced Lung Fibrosis
Distal lung epithelial progenitor cell function declines with age
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21
Functional and morphological differences of the lung upon acute and chronic ozone exposure in mice.
Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
Home
Biocellvia
Therapeutic Areas
Preclinical
Clinical
Tailor-made assay
Publications
Contact